Page 74 - GPD-4-2

Gene & Protein in Disease X chromosome in sex-biased autoimmunity

doi: 10.1016/1074-7613(94)90095-7 Manoussakis MN, Sfikakis PP. Aberrant expression of the
costimulatory molecule CD40 ligand on monocytes from
135. Armitage RJ, Fanslow WC, Strockbine L, et al. Molecular
and biological characterization of a murine ligand for CD40. patients with systemic lupus erythematosus. Clin Immunol.
Nature. 1992;357(6373):80-82. 2002;103(1):54-62.
doi: 10.1006/clim.2001.5172
doi: 10.1038/357080a0
143. Higuchi T, Aiba Y, Nomura T, et al. Cutting edge: Ectopic
136. Goules A, Tzioufas AG, Manousakis MN, Kirou KA,
Crow MK, Routsias JG. Elevated levels of soluble CD40 expression of CD40 ligand on B cells induces lupus-like
ligand (sCD40L) in serum of patients with systemic autoimmune disease. J Immunol. 2002;168(1):9-12.
autoimmune diseases. J Autoimmun. 2006;26(3):165-171. doi: 10.4049/jimmunol.168.1.9
doi: 10.1016/j.jaut.2006.02.002 144. Watanabe R, Berry GJ, Liang DH, Goronzy JJ, Weyand CM.
Pathogenesis of giant cell arteritis and takayasu
137. Stergiou IE, Poulaki A, Voulgarelis M. Pathogenetic mechanisms
implicated in sjogren’s syndrome lymphomagenesis: A review arteritis-similarities and differences. Curr Rheumatol
of the literature. J Clin Med. 2020;9(12):3794. Rep. 2020;22(10):68.
doi: 10.1007/s11926-020-00948-x
doi: 10.3390/jcm9123794
145. Hughes M, Pauling JD, Armstrong-James L, Denton CP,
138. Ramanujam M, Steffgen J, Visvanathan S, Mohan C, Fine JS,
Putterman C. Phoenix from the flames: Rediscovering Galdas P, Flurey C. Gender-related differences in systemic
the role of the CD40-CD40L pathway in systemic lupus sclerosis. Autoimmun Rev. 2020;19(4):102494.
erythematosus and lupus nephritis. Autoimmun Rev. doi: 10.1016/j.autrev.2020.102494
2020;19(11):102668.
146. Van Vollenhoven RF. Sex differences in rheumatoid arthritis:
doi: 10.1016/j.autrev.2020.102668 More than meets the eye. BMC Med. 2009;7:12.
139. Allard CC, Salti S, Mourad W, Hassan GS. Implications of doi: 10.1186/1741-7015-7-12
CD154 and its receptors in the pathogenesis and treatment 147. Linos A, Worthington JW, O’Fallon WM, Kurland LT.
of systemic lupus erythematosus. Cells. 2024;13(19):1621.
The epidemiology of rheumatoid arthritis in Rochester,
doi: 10.3390/cells13191621 Minnesota: A study of incidence, prevalence, and mortality.
Am J Epidemiol. 1980;111(1):87-98.
140. Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK.
Hyperexpression of CD40 ligand by B and T cells in human doi: 10.1093/oxfordjournals.aje.a112878
lupus and its role in pathogenic autoantibody production. 148. Taylor PN, Albrecht D, Scholz A, et al. Global epidemiology
J Clin Invest. 1996;97(9):2063-2073.
of hyperthyroidism and hypothyroidism. Nat Rev
doi: 10.1172/JCI118643 Endocrinol. 2018;14(5):301-316.
141. Koshy M, Berger D, Crow MK. Increased expression of doi: 10.1038/nrendo.2018.18
CD40 ligand on systemic lupus erythematosus lymphocytes. 149. Ngo ST, Steyn FJ, McCombe PA. Gender differences
J Clin Invest. 1996;98(3):826-837.
in autoimmune disease. Front Neuroendocrinol.
doi: 10.1172/JCI118855 2014;35(3):347-369.
142. Katsiari CG, Liossis SN, Souliotis VL, Dimopoulos AM, doi: 10.1016/j.yfrne.2014.04.004

Volume 4 Issue 2 (2025) 14 doi: 10.36922/gpd.8321